Credit Suisse Ag Catalyst Pharmaceuticals, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Credit Suisse Ag holds 117,399 shares of CPRX stock, worth $2.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

117,399

Previous 108,540 8.16%

Holding current value

$2.42 Million

Previous $1.82 Million 2.58%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$13.18 - $17.11 $116,761 - $151,577	8,859 Added 8.16%	117,399 $1.87 Million
Q4 2023 Feb 08, 2024	BUY	$11.78 - $17.29 $5,136 - $7,538	436 Added 0.4%	108,540 $1.82 Million
Q3 2023 Nov 13, 2023	SELL	$11.69 - $15.02 $394,233 - $506,534	-33,724 Reduced 23.78%	108,104 $1.26 Million
Q2 2023 Aug 11, 2023	BUY	$11.5 - $18.08 $646,622 - $1.02 Million	56,228 Added 65.69%	141,828 $1.91 Million
Q1 2023 May 10, 2023	BUY	$14.34 - $21.05 $33,684 - $49,446	2,349 Added 2.82%	85,600 $1.42 Million
Q4 2022 Feb 13, 2023	BUY	$12.25 - $19.5 $22,111 - $35,197	1,805 Added 2.22%	83,251 $1.55 Million
Q3 2022 Nov 10, 2022	BUY	$7.06 - $15.52 $85,694 - $188,381	12,138 Added 17.51%	81,446 $1.05 Million
Q2 2022 Aug 12, 2022	SELL	$6.23 - $8.57 $17,986 - $24,741	-2,887 Reduced 4.0%	69,308 $486,000
Q1 2022 May 16, 2022	SELL	$5.31 - $8.31 $9,966 - $15,597	-1,877 Reduced 2.53%	72,195 $598,000
Q4 2021 Feb 14, 2022	BUY	$5.21 - $7.45 $15,874 - $22,700	3,047 Added 4.29%	74,072 $501,000
Q3 2021 Nov 12, 2021	BUY	$4.85 - $6.04 $33,309 - $41,482	6,868 Added 10.7%	71,025 $376,000
Q2 2021 Aug 16, 2021	SELL	$4.29 - $6.05 $96,443 - $136,010	-22,481 Reduced 25.95%	64,157 $369,000
Q1 2021 May 14, 2021	SELL	$3.45 - $4.69 $368,825 - $501,389	-106,906 Reduced 55.24%	86,638 $399,000
Q4 2020 Feb 12, 2021	SELL	$2.97 - $3.83 $334,329 - $431,139	-112,569 Reduced 36.77%	193,544 $646,000
Q3 2020 Nov 13, 2020	BUY	$2.97 - $5.08 $31,125 - $53,238	10,480 Added 3.54%	306,113 $910,000
Q2 2020 Aug 12, 2020	SELL	$3.48 - $5.05 $84,657 - $122,851	-24,327 Reduced 7.6%	295,633 $1.37 Million
Q1 2020 May 13, 2020	SELL	$2.61 - $5.21 $631,914 - $1.26 Million	-242,113 Reduced 43.08%	319,960 $1.23 Million
Q4 2019 Feb 12, 2020	BUY	$3.67 - $5.7 $1.86 Million - $2.88 Million	505,667 Added 896.48%	562,073 $2.11 Million
Q3 2019 Nov 12, 2019	BUY	$3.89 - $7.43 $34,469 - $65,837	8,861 Added 18.64%	56,406 $300,000
Q2 2019 Aug 14, 2019	BUY	$2.7 - $6.11 $70,688 - $159,965	26,181 Added 122.55%	47,545 $182,000
Q1 2019 May 14, 2019	BUY	$2.11 - $5.33 $13,430 - $33,925	6,365 Added 42.44%	21,364 $110,000
Q4 2018 Feb 13, 2019	BUY	$1.92 - $3.62 $28,798 - $54,296	14,999 New	14,999 $29,000
Q3 2018 Nov 13, 2018	SELL	$2.81 - $3.78 $70,384 - $94,681	-25,048 Closed	0 $0
Q2 2018 Aug 14, 2018	SELL	$2.26 - $3.84 $13,639 - $23,174	-6,035 Reduced 19.42%	25,048 $78,000
Q1 2018 May 15, 2018	BUY	$2.39 - $4.01 $22,599 - $37,918	9,456 Added 43.72%	31,083 $75,000
Q4 2017 Feb 14, 2018	SELL	$2.51 - $4.4 $65,453 - $114,738	-26,077 Reduced 54.66%	21,627 $84,000
Q3 2017 Nov 14, 2017	BUY	$2.4 - $2.94 $80,940 - $99,151	33,725 Added 241.25%	47,704 $120,000
Q2 2017 Aug 14, 2017	BUY	N/A	13,979	13,979 $38,000

Others Institutions Holding CPRX

# of Institutions

326

Shares Held

94.6M

Call Options Held

19.1K

Put Options Held

51.1K

View Full List

About CATALYST PHARMACEUTICALS, INC.

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.12B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

More about CPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account